GLCACS 14th Annual Conference - Emerging Opportunities in Chemical and PharmaceuticalIndustries

• Time & Location:

May 15th 2010 (Saturday) 9:00-19:30

Northwestern University

Abbott Auditorium, Pancoe Building

2200 Campus Dr., Evanston, IL 60208st IL

• Eevent Agenda:

9:00-9:30 Registration/ Poster Mounting

9:30-9:45 Welcome

Dagang Huang, Ph.D., President, GLCACS 2010

Norman Li, Ph.D., Chairman of GLCACS Board of Directors

9:45-10:30 The Future Picture of Energy and the Challenges to China

Li Wang, Director and Chief Scientist of Catalysis at National Institute of Clean and Low-Carbon Energy ,Beijing, China

10:30-11:15 Getting things done in China

Lili Bovet , Executive Vice President, Cirrus Pharmaceuticals, Inc.

11:15-11:25 Break

11:25-12:30 Poster Presentation Competition

12:30-14:30 Poster Paper Competition

Career Counseling

Lunch Break

14:30-15:15 How Indigenous Chinese Manufacturers Compete in the Global Market

Ralph Biedermann, President of the MRB group and Partner of Chinaline,LLC

15:15-16:00 Elevance Renewable Sciences: Converting Renewable Materials into Sustainable Solutions for the Specialty Chemical Industry

Stephen A. Di Biase, Chief Scientific Officer, Elevance Renewable Sciences

16:00-16:15 Break / Final Competition Ballot Casting

16:15-16:30 Poster Competition Award and Closing Remark

17:30-19:30 Dinner Reception

---

• Guest Speakers:

The Future Picture of Energy and the Challenges to China - Dr. Li Wang

Dr. Li Wang

Director and Chief Scientist of Catalysis at National Institute of Clean and Low-Carbon

Energy ,Beijing, China

Abstract

The short “breather” that the global energy demand experienced, stemming from the economic slowdown, may soon end abruptly. The familiar scene of strong energy demand will inevitably return.

Despite the strong emphasis and efforts on developing renewable and new energy sources, for the foreseeable future, fossil fuels will continue to play a dominant role. Several factors support this view; the following are a few important ones. There is no readily available economic substitute for petroleum as a source for transportation fuels. Biofuels, based on the first-generation feedstocks, will contribute no more than 5-10% of the total transportation fuel demand; not a significant impact. The technology based on nonedible crops poses other yet to be resolved technological and soil management challenges. Yields of fuels produced from biomass are low, approximately 15% to 20% on a weight basis. The wind and solar energy, despite their rapid growth, will not provide a significant contribution to energy supplies in

the short term due to their high investment and production costs as well as limitations imposed by their inherent intermittency. Slow adoption of nuclear power in the developed world’s stationary energy sector, which is required to support the rapid growth of electric vehicles, will result in increased demand for fossil fuels.

China as a developing country experiencing strong growth no doubt will face a more difficult challenge in meeting its energy demand. Rich in coal, but poor in oil and gas, until technology advances to the point where new energy sources and alternative fuels become commercially viable, China will continue to rely on its most abundant natural resource - coal, to meet its energy needs. At the same time, China must face

the task of further optimizing the coal-to-energy conversion processes to eliminate deleterious environmental impacts and minimize the potential for adverse effects on climate. This mandate has led to the creation of National Institute of Clean and Low-Carbon Energy (NICE) which is chartered by the Chinese government and sponsored by the Shenhua Group, the world largest coal supplying company. In meeting the mandate, NICE will invent, develop, acquire and/or partner with resources of technology that render the coal chain more benign from an environmental perspective.

This talk will also briefly cover the primary activities of NICE on the conversion of coal to liquid fuels, chemicals and natural gas and the accompanied carbon and contaminants capture and sequestration. These activities undertaken by NICE should make China’s commitment to clean energy transparent.

Biography

Dr. Li Wang received his Ph. D. in Chemistry from the University of Wisconsin at Milwaukee in 1982. Dr. Wang began his R&D career with UOP right after his graduation working in the technology areas of catalytic reforming and FCC SOX getter. In 1989, he joined Honeywell Corporate Research working on the development of refrigerant catalysts, on-board methane storage and Nylon recycle. He returned to UOP, a company of Honeywell, in 1996 and joined the hydrocracking technology group, in the ten years that followed, he generated a new generation of hydrocracking catalyst portfolio which included 10 new catalysts. For this outstanding contribution, he was awarded the Honeywell’s Premier Award in 2007, the highest honor bestowed to individual by Honeywell. Dr. Wang retired from UOP as a Senior Fellow in August of 2009. He is now the Chief Scientist in Catalysis and Director of Catalysis in the National Institute of Clean and Low Carbon Energy in Beijing.

Getting things done in China - Dr. Lili Bovet

Dr. Lili Bovet

Executive Vice President, Cirrus Pharmaceuticals, Inc.

Abstract

China is one of the most populous countries in the world, and expected to continue the GDP growth between seven and nine percent annually in the next three to five years. To ensure affordable basic medicine supplying for all, the need for developing cost-effective and good quality generics in China is increasing. At the same time, with US health reform pressure, control of R&D cost for western pharmaceutical firms is also inevitable. China’s dynamic environment represents great emerging opportunities for biotech and pharmaceutical industry. This presentation will share experience in doing

business in China, and also address some of the issues related to how to get things done in China.

Biography

Dr. Lili Bovet has over 20 years of experience from a full range of research and product development activities to building and managing a pharmaceutical company in the biotechnology and pharmaceutical industry. As a partner at Cirrus Pharmaceuticals, Inc., she has extensive experience in building a company from the ground up. Her expertise extends from leading product development activities to managing

quality system, HR function, and business development.

Dr. Lili Bovet received her B.S. in Chemical Engineering from Tsinghua University in China. Then she earned her doctoral degree in Physical Chemistry, and continued her postdoctoral training in Pharmaceutical Science at the University of Michigan. She also earned her Master in Business Administration (M.B.A.) from Kenan-Flagler Business School at University of North Carolina.

Dr. Bovet worked in the inhalation product development department at GlaxoSmithKline and the formulation department at Schering-Plough Research Institute before joining Cirrus Pharmaceuticals. There, she has gained extensive experience in project management, full product development, and

regulatory affairs. She has also served as a consultant to several pharmaceutical companies in China, Japan, and U.S. She is also a certified Global Professional in Human Resources (GPHR).

How Indigenous Chinese Manufacturers Compete in the Global Market - Dr. Ralph A. Biedermann

Dr. Ralph A. Biedermann

President of The MRB Group and partner of Chinaline, LLC

Abbott Laboratories

Abstract

ChinaLine will take a close look at three privately owned Chinese manufacturing companies to examine how these companies grow in the global market. These three companies serve the personal care product, automotive component and appliance component segments of their respective industries. Now that China is significant part of the global economy, these companies compete in both the domestic Chinese market and in the rest of the world. Their competitive advantage is elaborated in light of their ownership structure, market positioning, manufacturing and R&D capability, and the nature of contractual relationships and partnerships with domestic customers and multinational corporations of the west. ChinaLine will conclude the presentation by offering comments and recommendations on how U.S. corporations can engage Chinese manufacturing companies in developing viable relationship options.

Biography

Dr. Biedermann is President of The MRB Group, an international market development firm, located in Lake Bluff, Illinois, and also a partner of ChinaLine, LLC, with offices in Chicago and Beijing. He has over 40 years experience in the industrial, consumer, defense and aerospace fields. The MRB Group works with U.S. and Canadian companies to develop and implement manufacturing, marketing and distribution strategies for Mexico, Central America, the Caribbean Basin and China. It also represents various private sector interests from those regions in the U.S. Before establishing The MRB Group in 1987, Dr. Biedermann was President of Brunswick International, Ltd., and Director of Corporate Relations for the Brunswick Corporation. Prior to that he worked for Northrop, General Electric and Grumman Aerospace in engineering and marketing positions.

He has served as Chairman of the Washington-based Committee for Production Sharing and Vice Chairman of the U.S. Government's Industry Sector Advisory Committee for Consumer Goods. Dr. Biedermann has been a member of the Board of Advisors of Georgetown University's Landegger Program in International

Business Diplomacy and a member of the Professional Services Group of the Fritz Companies, formerly the largest customhouse brokerage and marine insurance firm in the world (now part of UPS). He is a Board member of the U.S.-Mexico Chamber of Commerce and a member of the American Chamber of Commerce of China.

Dr. Biedermann also has been a Board member and former Vice President - Development for the Cove School in Northbrook, Illinois, and currently is an Adjunct Professor of Economics at DePaul University where he teaches a course on NAFTA. He is a former Board member of the International Trade Association of Greater Chicago. He has a BAE degree from Rensselaer Polytechnic Institute, an MBA from St. John's

University, and a DBA from The George Washington University.

He and his wife, Maureen, have two children and seven grandchildren.

Elevance Renewable Sciences: Converting Renewable Materials into Sustainable Solutions for the Specialty Chemical Industry - Dr. Stephen A. Di Biase

Dr. Stephen A. Di Biase

Chief Scientific Officer, Elevance Renewable Sciences

Abstract

Elevance is the first company to successfully bridge the renewables and chemicals industries, transforming natural renewable plant-based oils like soybean, canola, corn and sunflower into specialty chemical products.

We take raw ingredients and repurpose them without depleting the source using natural oil compounds and Nobel Prize-winning catalytic methods and patent-protected technologies. We use nature's own compounds to create something new and something exciting for application in Personal care and cosmetic applications, anti-microbials, industrial lubricants, and high-performance waxes and additives.

My talk will overview Elevance’s technology, applications and approach to building a unique specialty chemical company.

Biography

Dr. Stephen A. Di Biase serves as the Chief Scientific Officer for Elevance Renewable Sciences. In his role as Chief Scientific Officer he is responsible for innovation and product development efforts at a high technology start-up based on Nobel Prize winning technology.

Over the past 30+ year career Dr. Di Biase has become accomplished in application of innovation management in a global commercial setting. He has over 20 patents, has mentored hundreds of technical professionals and taught innovation and human resource management in both corporate and university settings. He has guest lectured at several academic institutions and has authored numerous patents and corporate publications.

Dr. Di Biase, a graduate from The Pennsylvania State University, is also a retired member of the Board of Trustees for the Mt. Union College, sits on the Science Advisory Board for The Pennsylvania State University, and has served on the Board of Directors of the Industrial Research Institute, a leading experience-based innovation management association.

Prior to joining Elevance renewable Sciences, Dr. Di Biase spent 5 years at Diversey as a Senior Vice President and Chief Scientific Officer and 26 years with the Lubrizol Corporation, where he held a variety of leadership positions, including general management roles and those with profit and loss responsibility for emerging businesses derived from technology platforms. These global assignments often involved business development from strategy conception to execution managing teams of Sales, Marketing, and Business Development professionals.

Prior to accepting the assignment in business development at Lubrizol, Dr. Di Biase was the Vice President – Research, Development, and Engineering where he was responsible for the global technical and scientific leadership for a centralized R&D function comprising of 700 professionals, an operating budget of $120+ million, and a capital budget of $10+ million. In this role Dr. Di Biase fostered innovation and delivered results using processes such as stage gates, project and portfolio management, 6- Sigma, and advanced statistics while introducing a variety of IT based tools like data mining and predictive modeling.

Dr. Di Biase has served as chairman of The Lubrizol Foundation Scholarship Committee, Chairman of theNortheastern Ohio Section of the American Chemical Society, Board member of the Cleveland Area Research Directors (CARD) and in The Boy Scouts of America where he served in a variety of posts. Dr. Di Biase has been honored by The Pennsylvania State University College of Science with its 2007

Distinguished Alumni Award and serves as an adjunct professor at Benedictine University in Naperville IL.

Conference brochure

• Research Presentation Contest Awardees: